Clinical trial
Pembrolizumab-PET Imaging
NCT02760225
Study timeline
Study start (actual)2016-10-24Date precision: day
Registry last updated2024-05-03
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Melanomaunresolved
Non-small Cell Lung Cancerunresolved
Interventions
89Zr-Pembrolizumab PETDEVICE
Sponsors & collaborators
University Medical Center Groningenlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02760225 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.